CSF-1 (M-CSF) differentially sensitizes mononuclear phagocyte subpopulations to endotoxin in vivo: A potential pathway that regulates the severity of gram-negative infections

Journal of Leukocyte Biology

Volumn 63, Issue 2, 1998, Pages 245-252

  Chapoval, Andrei I ^a   Kamdar, Sonya J ^a   Kremlev, Sergey G ^a   Evans, Robert ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

Endotoxic shock; Lipopolysaccharide; Macrophages

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; ENDOTOXIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTOXEMIA; GRAM NEGATIVE INFECTION; INFLAMMATORY CELL; MACROPHAGE FUNCTION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0031882076     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.63.2.245     Document Type: Article

References (32)

1. Roth, P., Stanley, E. R. (1992) The biology of CSF-1 and its receptor. Curr. Top. Microbiol. Immunol. 181, 141-167.
2. Evans, R., Kamdar, S. J., Duffy, T. M., Fuller, J. (1992) Synergistic interaction of bacterial lipopolysaccharide and the monocyte-macrophage colony-stimulating factor: potential quantitative and qualitative changes in macrophage-produced cytokine bioactivity. J. Leukoc. Biol. 51, 93-96.
3. Kamdar, S. J., Chapoval, A. I., Phelps, J., Fuller, J. A., Evans, R. (1996) Differential sensitivity of mouse mononuclear phagocytes to CSF-1 and LPS: the potential in vivo relevance of enhanced IL-6 gene expression. Cell Immunol. 174, 165-172.
4. Evans, R., Kamdar, S. J., Fuller, J. A., Krupke, D. M. (1995) The potential role of the macrophage colony-stimulating factor, CSF-1, in inflammatory responses: characterization of macrophage cytokine gene expression. J. Leukoc. Biol. 58, 99-107.
5. Hamilton, J. A., Whitty, G. A., Stanton, H., Meager, A. (1993) Effects of macrophage-colony stimulating factor on human monocytes: induction of expression of urokinase-type plasminogen activator, but not of secreted prostaglandin E2, interleukin-6, interleukin-1, or tumor necrosis factor-alpha. J. Leukoc. Biol. 53, 707-714.
6. Moore, R. N., Pitruzzello, F. J., Robinson, R. M., Rouse, B. T. (1985) Interferon produced endogenously in response to CSF-1 augments the functional differentiation of progeny macrophages. J. Leukoc. Biol. 37, 659-664.
7. Navarro, S., Debili, N., Bernaudin, J. F., Vainchenker, W., Doly, J. (1989) Regulation of the expression of IL-6 in human monocytes. J. Immunol. 142, 4339-4345.
8. Warren, M. K., Ralph, P. (1986) Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J. Immunol. 137, 2281-2285.
9. Kimball, E. S., Kovacs, E., Clark, M. C., Schneider, C. R. (1995) Activation of cytokine production and adhesion molecule expression on THP-1 myelomonocytic cells by macrophage colony-stimulating factor in combination with interferon-gamma. J. Leukoc. Biol. 58, 585-594.
10. Rutherford, M. S., Schook, L. B. (1992) Macrophage function in response to PGE2, L-arginine deprivation, and activation by colony-stimulating factors is dependent on hematopoietic stimulus. J. Leukoc. Biol. 52, 228-235.
11. Bone, R. C., Sprung, C. L., Sibbald, W. J. (1992) Definitions for sepsis and organ failure. Crit. Care Med. 20, 724-726.
12. Yoshimoto, T., Nakanishi, K., Hirose, S., Hiroishi, K., Okamura, H., Takemoto, Y., Kanamaru, A., Hada, T., Tamura, T., Kakishita, E. (1992) High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J. Immunol. 148, 3596-3603.
13. Galanos, C., Freudenberg, M. A. (1993) Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiol. 187, 346-356.
14. Wiktor-Jedrzejczak, W., Ahmed, A., Szczylik, C., Skelly, R. R. (1982) Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J. Exp. Med. 156, 1516-1527.
15. Szperl, M., Ansari, A. A., Urbanowska, E., Szwech, P., Kalinski, P., Wiktor-Jedrzejczak, W. (1995) Increased resistance of CSF-1-deficient, macrophage-deficient, TNF alpha-deficient, and IL-1 alpha-deficient op/op mice to endotoxin. Ann. NY Acad. Sci. 762, 499-501.
16. Wiktor-Jedrzejczak, W., Dzwigala, B., Szperl, M., Maruszynski, M., Urbanowska, E., Szwech, P. (1996) Colony-stimulating factor 1-dependent resident macrophages play a regulatory role in fighting Escherichia coli fecal peritonitis. Infect. Immun. 64, 1577-1581.
17. Ogretmen, B., Safa, A. R. (1995) Mini-preparation of total RNA for RT-PCR from cultured human cells. Biotechniques 19, 374-376.
18. Roth, P., Bartocci, A., Stanley, E. R. (1997) Lipopolysaccharide induces synthesis of mouse colony-stimulating factor-1 in vivo. J. Immunol. 158, 3874-3880.
19. Akira, S., Hirano, T., Taga, T., Kishimoto, T. (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL-1 and TNF). FASEB J. 4, 2860-2867.
20. Beutler, B., Cerami, A. (1989) The biology of cachectin/TNF-a primary mediator of the host response. Annu. Rev. Immunol. 7, 625-655.
21. Stanley, E. R., Guilbert, L. J., Tushinski, R. J., Bartelmez, S. H. (1983) CSF-1 - a mononuclear phagocyte lineage-specific hemopoietic growth factor. J. Cell Biochem. 21, 151-159.
22. Kelly, N. M., Cross, A. S. (1992) Interleukin-6 is a better marker of lethality than tumor necrosis factor in endotoxin treated mice. FEMS Microbiol. Immunol. 4, 317-322.
23. Damas, P., Ledoux, D., Nys, M., Vrindts, Y., De Groote, D., Franchimont, P., Lamy, M. (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215, 356-362.
24. Chen, B. D. (1991) In vivo administration of recombinant human interleukin-1 and macrophage colony-stimulating factor (M-CSF) induce a rapid loss of M-CSF receptors in mouse bone marrow cells and peritoneal macrophages: effect of administration route. Blood. 77, 1923-1928.
25. Beutler, B., Milsark, I. W., Cerami, A. (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869-871.
26. Cannon, J. G., Tompkins, R. G., Gelfand, J. A., Michie, H. R., Stanford, G. G., Van Der Meer, J. W., Endres, S., Lonnemann, G., Corsetti, J., Chernow, B. (1990) Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161, 79-84.
27. Hewett, J. A., Jean, P. A., Kunkel, S. L., Roth, R. A. (1993) Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury. Am. J. Physiol. 265, G1011-G1015.
28. Leist, M., Gantner, F., Bohlinger, I., Tiegs, G., Germann, P. G., Wendel, A. (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146, 1220-1234.
29. Bakouche, O., Ichinose, Y., Heicappell, R., Fidler, I. J., Lachman, L. B. (1988) Plasma membrane-associated tumor necrosis factor. A non-integral membrane protein possibly bound to its own receptor. J. Immunol. 140, 1142-1147.
30. Schmid, I., Baldwin, G. C., Jacobs, E. L., Isacescu, V., Neagos, N., Giorgi, J. V., Glaspy, J. A. (1995) Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF. Cytometry 22, 103-110.
31. Bartholeyns, J., Freudenberg, M. A., Galanos, C. (1987) Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor. Infect. Immun. 55, 2230-2233.
32. Matsuura, M., Galanos, C. (1990) Induction of hypersensitivity to endotoxin and tumor necrosis factor by sublethal infection with Salmonella typhimurium. Infect. Immun. 58, 935-937.